Sales/Marketing Sway In Educational Grants Under Scrutiny By Senate
Executive Summary
The Senate Finance Committee is asking drug companies to explain the role sales and marketing executives play in educational grants bestowed to professional societies
You may also be interested in...
Senate Finance Committee investigating J&J
The Senate Finance Committee is seeking information from Johnson & Johnson on medical education activities the company funded for its heartburn drug Propulsid (cisapride). A July 5 letter to the company from committee Chairman Charles Grassley (R-Iowa) and Ranking Member Max Baucus (D-Mont.) cites a June New York Times article discussing promotion of Propulsid's use in children before the company ceased marketing the product in 2000. The committee asks J&J to identify specific dollar amounts for educational grants and employees responsible for those grants between 1993 and 2000...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials